Patents by Inventor Wen Liang Yan

Wen Liang Yan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240124350
    Abstract: A quantum dot composite structure and a method for forming the same are provided. The quantum dot composite structure includes: a glass particle including a glass matrix and a plurality of quantum dots located in the glass matrix, wherein at least one of the plurality of quantum dots includes an exposed surface in the glass matrix; and an inorganic protective layer disposed on the glass particle and covering the exposed surface.
    Type: Application
    Filed: October 13, 2023
    Publication date: April 18, 2024
    Inventors: Ching LIU, Wen-Tse HUANG, Ru-Shi LIU, Pei Cong YAN, Chai-Chun HSIEH, Hung-Chun TONG, Yu-Chun LEE, Tzong-Liang TSAI
  • Publication number: 20080260707
    Abstract: The present invention discloses and describes pluripotent homozygous stem (HS) cells, and methods and materials for making same. The present invention also provides methods for differentiation of HS cells into progenitor (multipotent) cells or other desired cells, groups of cells or tissues. Further, the applications of the HS cells disclosed herein, include (but are not limited to) the diagnosis and treatment of various diseases (for example, genetic diseases, neurodegenerative diseases, endocrine-related disorders and cancer), traumatic injuries, cosmetic or therapeutic transplantation, gene therapy and cell replacement therapy.
    Type: Application
    Filed: April 4, 2008
    Publication date: October 23, 2008
    Applicant: Stemron, Inc.
    Inventors: Wen Liang Yan, Steve Chien-Wen Huang, Minh-Thanh Nguyen, Hua Helen Lin, Jingqi Lei, Ruchi Khanna
  • Patent number: 7030292
    Abstract: A method of producing a homogenous population of homozygous stem (HS) cells pre-selected for immunotype and/or genotype from donor cells is described herein. The invention relates to methods of using immunohistocompatible HS cells for diagnosis, therapeutic and cosmetic transplantation, and the treatment of various genetic diseases, neurodegenerative diseases, traumatic injuries and cancer. The invention further relates to methods for using histocompatible HS stem cells pre-selected for a non-disease genotype for prophylactic and therapeutic intervention including, but not limited to, therapeutic and cosmetic transplantation, and the treatment of various genetic diseases, neurodegenerative diseases, and cancer.
    Type: Grant
    Filed: January 2, 2002
    Date of Patent: April 18, 2006
    Assignee: Stemron, Inc.
    Inventors: Wen Liang Yan, Steve Chien-Wen Huang, Minh-Thanh Nguyen, Huan (Helen) Lin, Jingqi Lei, Ruchi Khanna
  • Publication number: 20030027331
    Abstract: The present invention discloses and describes pluripotent homozygous stem (HS) cells, and methods and materials for making same. The present invention also provides methods for differentiation of HS cells into progenitor (multipotent) cells or other desired cells, groups of cells or tissues. Further, the applications of the HS cells disclosed herein, include (but are not limited to) the diagnosis and treatment of various diseases (for example, genetic diseases, neurodegenerative diseases, endocrine-related disorders and cancer), traumatic injuries, cosmetic or therapeutic transplantation, gene therapy and cell replacement therapy.
    Type: Application
    Filed: June 26, 2002
    Publication date: February 6, 2003
    Inventors: Wen Liang Yan, Steve Chien-Wen Huang, Minh-Thanh Nguyen, Hua Lin, Lei Jingqi, Ruchi Khanna
  • Publication number: 20020168763
    Abstract: The present invention discloses and describes pluripotent homozygous stem (HS) cells, and methods and materials for making same. The present invention also provides methods for differentiation of HS cells into progenitor (multipotent) cells or other desired cells, groups of cells or tissues. Further, the applications of the HS cells disclosed herein, include (but are not limited to) the diagnosis and treatment of various diseases (for example, genetic diseases, neurodegenerative diseases, endocrine-related disorders and cancer), traumatic injuries, cosmetic or therapeutic transplantation, gene therapy and cell replacement therapy.
    Type: Application
    Filed: November 30, 2001
    Publication date: November 14, 2002
    Inventors: Wen Liang Yan, Steve Chien-Wen Huang, Minh-Thanh Nguyen, Hua (Helen) Lin, Jingqi Lei, Ruchi Khanna
  • Publication number: 20020155601
    Abstract: A method of producing a homogenous population of homozygous stem (HS) cells pre-selected for immunotype and/or genotype from donor cells is described herein. The invention relates to methods of using immunohistocompatible HS cells for diagnosis, therapeutic and cosmetic transplantation, and the treatment of various genetic diseases, neurodegenerative diseases, traumatic injuries and cancer. The invention further relates to methods for using histocompatible HS stem cells pre-selected for a non-disease genotype for prophylactic and therapeutic intervention including, but not limited to, therapeutic and cosmetic transplantation, and the treatment of various genetic diseases, neurodegenerative diseases, and cancer.
    Type: Application
    Filed: January 2, 2002
    Publication date: October 24, 2002
    Inventors: Wen Liang Yan, Steve Chien-Wen Huang, Minh-Thanh Nguyen, Hua (Helen) Lin, Jingqi Lei, Ruchi Khanna